中医药与肠道微生态相关性研究进展
|
摘要
人体微生态系统包括口腔、皮肤、尿液和胃肠道,肠道微生态系统是最重要、最复杂的生态系统。肠道微生态由肠道菌群和其寄居的环境组成,具有参与机体物质代谢、营养吸收、黏膜屏障、免疫调节等作用,与机体生理及病理活动关系密切,相互影响。人体微生物群落由细菌、真菌、病毒和古菌等组成,他们之间建立了高度复杂的相互作用网络。肠道微生物生物量占人体微生物总生物量的78%,约有400～500种肠道细菌。正常肠道菌群是人体的天然屏障,对维持人体健康起着重要作用。肠道菌群最显著特征之一是具有稳定性,菌群按一定比例组合,各种细菌相互制约、相互依赖,在质量和数量上形成生态平衡。人体内外环境的变化会影响肠道菌群数量及结构,特别是长期使用广谱抗生素,敏感肠杆菌受到抑制,会发生各种肠道疾病和肠外疾病。因此,维持肠道微生态平衡对于人类抵抗肠道病原体引起的传染病具有重要意义。近年来,国内外学者发现,肠道微生态与消化系统疾病、心脑血管疾病、代谢综合征、肥胖等关系密切。关于中医药与肠道微生态的实验和临床研究日益增多,中医药也成为打开肠道微生态大门的一把金钥匙。文章从中医病因病机、证候、实验研究及临床治疗方面着手,系统论述了中医药与肠道微生态的相关性。
Human microecosystem includes oral cavity,skin,urine and gastrointestinal tract. Intestinal microecosystem is the most important and complex ecosystem. Intestinal microecology is composed of intestinal microflora and its habitat environment. It plays an important role in substance metabolism,nutrient absorption,mucosal barrier,immune regulation,and is closely related to physiological and pathological activities of the body.Human microbial community is composed of bacteria,fungi,viruses and archaea,which have established a highly complex interaction network. Intestinal microbial biomass accounts for 78% of the total human microbial biomass,and there are about 400 to 500 kinds of intestinal bacteria. Normal intestinal flora is the natural barrier of human body,and plays an important role in maintaining human health. One of the most prominent characteristics of intestinal flora is stability. The flora is combined in a certain proportion,and all kinds of bacteria interact with and depend on each other to form an ecological balance in quality and quantity. Any change in the internal and external environment of the human body will affect the number and structure of intestinal flora. In particular,the long-term use of broad-spectrum antibiotics could inhite susceptible enterobacter,which would cause various intestinal diseases and parenteral diseases. Therefore,the maintenance of intestinal microecological balance is of great significance to human' s resistance to infectious diseases caused by intestinal pathogens. In recent years,scholars at home and abroad have found that intestinal microecology is closely related to digestive system diseases,cardiovascular and cerebrovascular diseases,metabolic syndrome,obesity and so on. With the increasing number of experimental and clinical studies on traditional Chinese medicine( TCM) and intestinal microecology,TCM has become a golden key to open the door of intestinal microecology. This paper systematically discussed the correlation between TCM and intestinal microecology in the aspects of etiology,pathogenesis,syndrome,experimental research and clinical treatment.
Human microecosystem includes oral cavity,skin,urine and gastrointestinal tract. Intestinal microecosystem is the most important and complex ecosystem. Intestinal microecology is composed of intestinal microflora and its habitat environment. It plays an important role in substance metabolism,nutrient absorption,mucosal barrier,immune regulation,and is closely related to physiological and pathological activities of the body.Human microbial community is composed of bacteria,fungi,viruses and archaea,which have established a highly complex interaction network. Intestinal microbial biomass accounts for 78% of the total human microbial biomass,and there are about 400 to 500 kinds of intestinal bacteria. Normal intestinal flora is the natural barrier of human body,and plays an important role in maintaining human health. One of the most prominent characteristics of intestinal flora is stability. The flora is combined in a certain proportion,and all kinds of bacteria interact with and depend on each other to form an ecological balance in quality and quantity. Any change in the internal and external environment of the human body will affect the number and structure of intestinal flora. In particular,the long-term use of broad-spectrum antibiotics could inhite susceptible enterobacter,which would cause various intestinal diseases and parenteral diseases. Therefore,the maintenance of intestinal microecological balance is of great significance to human' s resistance to infectious diseases caused by intestinal pathogens. In recent years,scholars at home and abroad have found that intestinal microecology is closely related to digestive system diseases,cardiovascular and cerebrovascular diseases,metabolic syndrome,obesity and so on. With the increasing number of experimental and clinical studies on traditional Chinese medicine( TCM) and intestinal microecology,TCM has become a golden key to open the door of intestinal microecology. This paper systematically discussed the correlation between TCM and intestinal microecology in the aspects of etiology,pathogenesis,syndrome,experimental research and clinical treatment.
引文
[1] Sittipo P,Lobionda S,Lee Y K,et al. Intestinal microbiota and the immune system in metabolic diseases[J]. J Microbiol,2018,56(3):154-162.
[2]俞晖媛,陈洁.肠道菌群在代谢综合征发病中的作用及机制研究进展[J].国际消化病杂志,2018,38(1):19-23.
[3] Janssen A W F,Kersten S. The role of the gut microbiota in metabolic health[J]. FASEB J,2015,29(8):3111-3123.
[4] LI Y,LIU T,YAN C,et al. Diammonium glycyrrhizinate protects against nonalcoholic fatty liver disease in mice through modulation of gut microbiota and restoration of intestinal barrier[J]. Mol Pharm,2018,15(9):3860-3870.
[5] XU P,Becker H,Elizalde M,et al. Intestinal organoid culture model is a valuable system to study epithelial barrier function in IBD[J]. Gut,2018,67(10):1905-1906.
[6] LIU Y,ZHANG L,WANG X,et al. Similar fecal microbiota signatures in patients with diarrheapredominant irritable bowel syndrome and patients with depression[J]. Clin Gastroenterol Hepatol,2016,14(11):1602-1611.
[7] YUAN Y,SUN Z M,ZHANG Y,et al. Influence of gut microecology on the pathogenesis and treatment of nonalcoholic fatty liver disease[J]. Chin J Hepatol,2016,24(5):375-379.
[8] Szereday L,Meggyes M,Halasz M,et al. Immunological changes in different patient populations with chronic hepatitis C virus infection[J]. World J Gastroenterol,2016,22(20):4848-4859.
[9] LIN L,WEN Z B,LIN D J,et al. Correlations between microbial communities in stool and clinical indicators in patients with metabolic syndrome[J]. World J Clin Cases,2018,6(4):54-63.
[10]韩文贝,刘莹露,万毅刚,等.慢性肾脏病肠道菌群失调的病理机制、治疗策略及中药的干预作用[J].中国中药杂志,2017,42(13):2425-2432.
[11] PAN L,CHEN Y,LI H,et al. Dachengqi decoction attenuates intestinal vascular endothelial injury in severe acute pancreatitis in vitro and in vivo[J]. Cell Physiol Biochem,2017,44(6):2395-2406.
[12] PAN L,CHEN Y,LI H,et al. Changes in small intestinal motility and related hormones by acupuncture stimulation at Zusanli(ST 36)in mice[J]. Chin J Integr Med,2017,23(3):215-220.
[13]邵晓姣,成泽东.从中医阴阳五行理论谈肠道菌群[J].辽宁中医药大学学报,2013,15(7):136-137.
[14]封慧,朱欣轶,王长松.健脾中药对肠道微生态作用机制研究进展[J].中国中医药信息杂志,2018,25(10):137-140.
[15]马祥雪,王凤云,符竣杰,等.基于肠道菌群的中医健脾方剂作用机制的研究现状与思考[J].中国实验方剂学杂志,2017,23(5):210-215.
[16] WU X, TIAN Z. Gut-liver axis:gut microbiota in shaping hepatic innate immunity[J]. Sci China Life Sci,2017,60(11):1191-1196.
[17]何毅芳,杨钦河,张玉佩,等.从肝脾相关理论探讨中医药防治慢性肝病的思路与方法[J].中医学报,2017,32(7):1206-1208.
[18]郑秀丽,杨宇,郑旭锐,等.从肺肠菌群变化的相关性探讨“肺与大肠相表里”[J].中华中医药杂志,2013,28(8):2294-2296.
[19]郑海涛,范奕熳,袁海霞,等.基于中医“肺与大肠相表里”理论的肠道菌群对机体免疫的影响[J].时珍国医国药,2018,29(5):1170-1172.
[20]张玉,张军峰,杨亚平.近十五年来肠道微生态的中医药研究概况[J].辽宁中医杂志,2016,43(11):2442-2445.
[21]吴国琳,余国友,卢雯雯.肠道微生态的中医本质探讨[J].中华中医药学刊,2015,33(11):2586-2588.
[22]覃佩兰,成泽东.基于脑肠轴学说探讨针灸对肠道菌群调节的思考[J].时珍国医国药,2015,26(11):2712-2714.
[23]田祖宏,聂勇战.肠道微生物与脑-肠轴交互作用的研究进展[J].传染病信息,2016,29(5):302-307.
[24] Ogbonnaya E S,Clarke G,Shanahan F,et al. Adult hippocampal neurogenesis is regulated by the microbiome[J]. Biol Psychiatry,2015,78(4):7-9.
[25]刘雷蕾,孟静岩.从中医基础理论角度认识肠道微生态[J].北京中医药大学学报,2016,39(9):724-727.
[26]杨化冰,邹小娟,孔明望,等.肠道微生态与传统中医思想内涵[J].中医杂志,2017,58(12):1070-1072.
[27]黄腾杰,李英帅,骆斌.基于肠道微生态对中医体质理论的微观阐释[J].北京中医药大学学报,2015,38(5):299-302,326.
[28]张北华,王凤云,卞兆祥,等.证候表型与肠道微生态的相关性[J].中医杂志,2018,59(1):21-25.
[29]邵铁娟,李海昌,谢志军,等.基于脾主运化理论探讨脾虚湿困与肠道菌群紊乱的关系[J].中华中医药杂志,2014,29(12):3762-3765.
[30]石杨,于洪宇.参苓白术散治疗脾虚泄泻模型小鼠肠道局部免疫机制研究[J].免疫学杂志,2018,34(6):519-523.
[31]程成,张军峰,史丽云.湿热证与肠道微生态[J].南京中医药大学学报,2018,34(2):210-213.
[32]王瑞琼,吴国泰,杨志军,等.郁金散对抗生素相关性大肠湿热证大鼠肠黏膜屏障损伤的修复作用[J].中国现代应用药学,2018,35(4):529-536.
[33]姚万玲.大肠湿热证实质及郁金散对其治疗作用机理研究[D].兰州:甘肃农业大学,2017.
[34]王均衡.阳虚质粪便代谢组学特征及其与肠道菌群结构的相关性研究[D].北京:北京中医药大学,2017.
[35]李英帅,黄腾杰,李玲孺,等.阳虚质肠道菌群与宿主代谢共变化机制研究[J].中华中医药学刊,2015,33(7):1568-1570.
[36]黄腾杰.阳虚质肠道菌群结构特征研究[D].北京:北京中医药大学,2015.
[37]陈亚琳,余丹丹,潘研,等.肠道菌群失调的中医药治疗[J].世界中西医结合杂志,2018,13(6):879-882.
[38]陈滔彬,姚宏亮,严曾豪,等.肠道微生态对疾病的影响及其与中药的相互作用研究进展[J].中南药学,2018,16(3):382-388.
[39] FU Y P,FENG B,ZHU Z K,et al. The polysaccharides from codonopsis pilosula codulates the immunity and intestinal microbiota of cyclophosphamide-treated immunosuppressed mice[J]. Molecules,2018,23(7):1801-1814.
[40] XU N,KAN P,YAO X,et al. Astragaloside IV reversed the autophagy and oxidative stress induced by the intestinal microbiota of AIS in mice[J]. J Microbiol,2018,56(11):838-846.
[41]郭抗萧,彭买姣,彭昕欣,等.七味白术散对菌群失调腹泻小鼠肠道细菌多样性的影响[J].微生物学通报,2018,45(7):1470-1478.
[42] LUO L, ZHOU Z, XUE J, et al. Bletilla striatapolysaccharide has a protective effect on intestinal epithelial barrier disruption in TAA-induced cirrhotic rats[J]. Exp Ther Med,2018,16(3):1715-1722.
[43]钟瑜萍,郑作亮,李海燕,等.大黄-黄芪不同剂量配比对慢性肾功能衰竭大鼠肠粘膜和肠道菌群移位的影响[J].中药药理与临床,2017,33(2):130-133.
[44]刘翠英,施家希,黄娟,等.参苓白术散对溃疡性结肠炎小鼠紧密连接及MLCK/MLC通路的影响[J].中药材,2018,41(9):1928-1932.
[45]方晶.基于肠道菌群对肠粘膜机械屏障影响探讨大黄泽泻汤治疗NAFLD机制的研究[D].南京:南京中医药大学,2018.
[46]侯洪涛,裘艳梅,冯佳,等.姜黄素对非酒精性脂肪肝病大鼠肠道s Ig A及氧化应激的影响[J].广东医学,2018,39(8):1133-1136.
[47]蔚志仁,石晶,王彩霞,等.参苓白术散加减治疗脾虚湿蕴型亚急性湿疹临床疗效及对炎症因子和外周血T淋巴细胞亚群的影响[J].中国实验方剂学杂志,2019,25(5):63-67.
[48]蔺晓源,余星,雷贵玥,等.健脾益肠散对溃疡性结肠炎大鼠结肠组织HSP70表达的影响[J].中国实验方剂学杂志,2017,23(22):91-96.
[49]安婉丽,李雪丽,孔冉,等.中医药治疗肠道菌群失调症的方剂用药规律分析[J].中国实验方剂学杂志,2018,24(12):210-215.
[50]杜旦锋,郭丽,祝利民.大肠癌微生态与脾虚证的相关研究现状及思考[J].浙江中医杂志,2018,53(2):154-155.
[51]张玉佩,杨钦河,邓远军,等.中焦湿热证与胃肠道微生态关系刍议[J].中医杂志,2016,57(24):2094-2096.
[52]吴云,陈瑞,田维毅.苦寒中药对肠道菌群结构影响的研究进展[J].中国微生态学杂志,2015,27(2):235-239.
[53]崔国宁,刘喜平,曾庆涛.参苓白术散治疗溃疡性结肠炎研究进展[J].中华中医药学刊,2018,36(2):391-395.
[54]劳武健,邓亮,吴青志.参苓白术颗粒联合匹维溴铵治疗腹泻型肠易激综合征的临床观察[J].云南中医中药杂志,2018,39(9):50-52.
[55]李军婷,张美琳,李卓.参苓白术散联合双歧三联活菌胶囊治疗抗生素相关腹泻疗效分析[J].云南中医学院学报,2018,41(2):41-43.
[56]李铁,刘平,及东林.参苓白术散联合盐酸洛哌丁胺胶囊治疗腹腔镜胆囊切除术后腹泻疗效及对肠道菌群及胃肠激素的影响[J].现代中西医结合杂志,2017,26(19):2097-2101.
[57]冯新格,严育忠,曾艺鹏,等.葛根芩连汤对2型糖尿病湿热证肠道菌群的影响[J].世界中西医结合杂志,2016,11(8):1110-1112.
[58]谭朝晖,刘荣火,邹立华,等.白头翁汤对溃疡性结肠炎黏膜愈合的影响及部分机制研究[J].中国中医药信息杂志,2016,23(7):30-34.
[59]刘靖.痛泻要方治疗腹泻型肠易激综合征的疗效观察及其对肠道菌群的影响[D].北京:中国中医科学院,2017.
[60]陈维,孟宪萌,关乐,等.大柴胡汤对冠心病不稳定型心绞痛血清Ghrelin和Obestatin的表达及肠道菌群构成的影响[J].中国实验方剂学杂志,2018,24(12):169-174.
[61]钟雄利,谭小燕,任伟旺,等.大承气汤联合西医治疗重症急性胰腺炎的疗效及其对肠黏膜屏蔽功能的影响[J].中国中西医结合消化杂志,2015,23(4):242-244.
[62]张双喜,张相安,安永康.济川煎对老年慢性功能性便秘患者胃肠功能、血清肠神经递质及肠道菌群的影响[J].中国实验方剂学杂志,2018,24(22):169-174.
[63]余静芳.理中汤联合恩替卡韦对乙型肝炎肝硬化代偿期肠道微生态的影响[D].南宁:广西中医药大学,2017.
[64]李吉武,唐爱华,赵伟,等.温阳益气活血方对肥胖2型糖尿病患者肠道菌群变化及脂质代谢的影响[J].中医杂志,2015,56(5):409-413.
[65]李超然,刘德柱,杨燕,等.针灸对慢性疲劳综合征及肠道菌群的作用研究[J].针灸临床杂志,2018,34(7):89-92.
[66]覃佩兰,成泽东.基于脑肠轴学说探讨针灸对肠道菌群调节的思考[J].时珍国医国药,2015,26(11):2712-2714.
[67]苏冬梅,刘新平,黄静娟,等.神阙穴隔姜灸对腹泻型肠易激综合征患者肠道双歧杆菌影响[J].辽宁中医药大学学报,2018,20(5):135-138.
[68]高小明,常虹,丁超华.柴芍承气汤灌肠联合生长抑素对重症胰腺炎患者腹内高压及肠道黏膜屏障的影响[J].中医药导报,2017,23(6):96-98.
[69]王荣荣,曹志尉,孟静.大黄牡丹汤保留灌肠联合血液净化治疗重症急性胰腺炎的临床疗效及对患者肠黏膜屏障功能和炎症因子的影响[J].中国中医急症,2018,27(9):1618-1620.
[70]孔月晴,赵振宇.拔罐合耳穴贴压疗法对单纯性肥胖患者肠道菌群的影响[J].中国临床研究,2016,29(2):257-259.
[2]俞晖媛,陈洁.肠道菌群在代谢综合征发病中的作用及机制研究进展[J].国际消化病杂志,2018,38(1):19-23.
[3] Janssen A W F,Kersten S. The role of the gut microbiota in metabolic health[J]. FASEB J,2015,29(8):3111-3123.
[4] LI Y,LIU T,YAN C,et al. Diammonium glycyrrhizinate protects against nonalcoholic fatty liver disease in mice through modulation of gut microbiota and restoration of intestinal barrier[J]. Mol Pharm,2018,15(9):3860-3870.
[5] XU P,Becker H,Elizalde M,et al. Intestinal organoid culture model is a valuable system to study epithelial barrier function in IBD[J]. Gut,2018,67(10):1905-1906.
[6] LIU Y,ZHANG L,WANG X,et al. Similar fecal microbiota signatures in patients with diarrheapredominant irritable bowel syndrome and patients with depression[J]. Clin Gastroenterol Hepatol,2016,14(11):1602-1611.
[7] YUAN Y,SUN Z M,ZHANG Y,et al. Influence of gut microecology on the pathogenesis and treatment of nonalcoholic fatty liver disease[J]. Chin J Hepatol,2016,24(5):375-379.
[8] Szereday L,Meggyes M,Halasz M,et al. Immunological changes in different patient populations with chronic hepatitis C virus infection[J]. World J Gastroenterol,2016,22(20):4848-4859.
[9] LIN L,WEN Z B,LIN D J,et al. Correlations between microbial communities in stool and clinical indicators in patients with metabolic syndrome[J]. World J Clin Cases,2018,6(4):54-63.
[10]韩文贝,刘莹露,万毅刚,等.慢性肾脏病肠道菌群失调的病理机制、治疗策略及中药的干预作用[J].中国中药杂志,2017,42(13):2425-2432.
[11] PAN L,CHEN Y,LI H,et al. Dachengqi decoction attenuates intestinal vascular endothelial injury in severe acute pancreatitis in vitro and in vivo[J]. Cell Physiol Biochem,2017,44(6):2395-2406.
[12] PAN L,CHEN Y,LI H,et al. Changes in small intestinal motility and related hormones by acupuncture stimulation at Zusanli(ST 36)in mice[J]. Chin J Integr Med,2017,23(3):215-220.
[13]邵晓姣,成泽东.从中医阴阳五行理论谈肠道菌群[J].辽宁中医药大学学报,2013,15(7):136-137.
[14]封慧,朱欣轶,王长松.健脾中药对肠道微生态作用机制研究进展[J].中国中医药信息杂志,2018,25(10):137-140.
[15]马祥雪,王凤云,符竣杰,等.基于肠道菌群的中医健脾方剂作用机制的研究现状与思考[J].中国实验方剂学杂志,2017,23(5):210-215.
[16] WU X, TIAN Z. Gut-liver axis:gut microbiota in shaping hepatic innate immunity[J]. Sci China Life Sci,2017,60(11):1191-1196.
[17]何毅芳,杨钦河,张玉佩,等.从肝脾相关理论探讨中医药防治慢性肝病的思路与方法[J].中医学报,2017,32(7):1206-1208.
[18]郑秀丽,杨宇,郑旭锐,等.从肺肠菌群变化的相关性探讨“肺与大肠相表里”[J].中华中医药杂志,2013,28(8):2294-2296.
[19]郑海涛,范奕熳,袁海霞,等.基于中医“肺与大肠相表里”理论的肠道菌群对机体免疫的影响[J].时珍国医国药,2018,29(5):1170-1172.
[20]张玉,张军峰,杨亚平.近十五年来肠道微生态的中医药研究概况[J].辽宁中医杂志,2016,43(11):2442-2445.
[21]吴国琳,余国友,卢雯雯.肠道微生态的中医本质探讨[J].中华中医药学刊,2015,33(11):2586-2588.
[22]覃佩兰,成泽东.基于脑肠轴学说探讨针灸对肠道菌群调节的思考[J].时珍国医国药,2015,26(11):2712-2714.
[23]田祖宏,聂勇战.肠道微生物与脑-肠轴交互作用的研究进展[J].传染病信息,2016,29(5):302-307.
[24] Ogbonnaya E S,Clarke G,Shanahan F,et al. Adult hippocampal neurogenesis is regulated by the microbiome[J]. Biol Psychiatry,2015,78(4):7-9.
[25]刘雷蕾,孟静岩.从中医基础理论角度认识肠道微生态[J].北京中医药大学学报,2016,39(9):724-727.
[26]杨化冰,邹小娟,孔明望,等.肠道微生态与传统中医思想内涵[J].中医杂志,2017,58(12):1070-1072.
[27]黄腾杰,李英帅,骆斌.基于肠道微生态对中医体质理论的微观阐释[J].北京中医药大学学报,2015,38(5):299-302,326.
[28]张北华,王凤云,卞兆祥,等.证候表型与肠道微生态的相关性[J].中医杂志,2018,59(1):21-25.
[29]邵铁娟,李海昌,谢志军,等.基于脾主运化理论探讨脾虚湿困与肠道菌群紊乱的关系[J].中华中医药杂志,2014,29(12):3762-3765.
[30]石杨,于洪宇.参苓白术散治疗脾虚泄泻模型小鼠肠道局部免疫机制研究[J].免疫学杂志,2018,34(6):519-523.
[31]程成,张军峰,史丽云.湿热证与肠道微生态[J].南京中医药大学学报,2018,34(2):210-213.
[32]王瑞琼,吴国泰,杨志军,等.郁金散对抗生素相关性大肠湿热证大鼠肠黏膜屏障损伤的修复作用[J].中国现代应用药学,2018,35(4):529-536.
[33]姚万玲.大肠湿热证实质及郁金散对其治疗作用机理研究[D].兰州:甘肃农业大学,2017.
[34]王均衡.阳虚质粪便代谢组学特征及其与肠道菌群结构的相关性研究[D].北京:北京中医药大学,2017.
[35]李英帅,黄腾杰,李玲孺,等.阳虚质肠道菌群与宿主代谢共变化机制研究[J].中华中医药学刊,2015,33(7):1568-1570.
[36]黄腾杰.阳虚质肠道菌群结构特征研究[D].北京:北京中医药大学,2015.
[37]陈亚琳,余丹丹,潘研,等.肠道菌群失调的中医药治疗[J].世界中西医结合杂志,2018,13(6):879-882.
[38]陈滔彬,姚宏亮,严曾豪,等.肠道微生态对疾病的影响及其与中药的相互作用研究进展[J].中南药学,2018,16(3):382-388.
[39] FU Y P,FENG B,ZHU Z K,et al. The polysaccharides from codonopsis pilosula codulates the immunity and intestinal microbiota of cyclophosphamide-treated immunosuppressed mice[J]. Molecules,2018,23(7):1801-1814.
[40] XU N,KAN P,YAO X,et al. Astragaloside IV reversed the autophagy and oxidative stress induced by the intestinal microbiota of AIS in mice[J]. J Microbiol,2018,56(11):838-846.
[41]郭抗萧,彭买姣,彭昕欣,等.七味白术散对菌群失调腹泻小鼠肠道细菌多样性的影响[J].微生物学通报,2018,45(7):1470-1478.
[42] LUO L, ZHOU Z, XUE J, et al. Bletilla striatapolysaccharide has a protective effect on intestinal epithelial barrier disruption in TAA-induced cirrhotic rats[J]. Exp Ther Med,2018,16(3):1715-1722.
[43]钟瑜萍,郑作亮,李海燕,等.大黄-黄芪不同剂量配比对慢性肾功能衰竭大鼠肠粘膜和肠道菌群移位的影响[J].中药药理与临床,2017,33(2):130-133.
[44]刘翠英,施家希,黄娟,等.参苓白术散对溃疡性结肠炎小鼠紧密连接及MLCK/MLC通路的影响[J].中药材,2018,41(9):1928-1932.
[45]方晶.基于肠道菌群对肠粘膜机械屏障影响探讨大黄泽泻汤治疗NAFLD机制的研究[D].南京:南京中医药大学,2018.
[46]侯洪涛,裘艳梅,冯佳,等.姜黄素对非酒精性脂肪肝病大鼠肠道s Ig A及氧化应激的影响[J].广东医学,2018,39(8):1133-1136.
[47]蔚志仁,石晶,王彩霞,等.参苓白术散加减治疗脾虚湿蕴型亚急性湿疹临床疗效及对炎症因子和外周血T淋巴细胞亚群的影响[J].中国实验方剂学杂志,2019,25(5):63-67.
[48]蔺晓源,余星,雷贵玥,等.健脾益肠散对溃疡性结肠炎大鼠结肠组织HSP70表达的影响[J].中国实验方剂学杂志,2017,23(22):91-96.
[49]安婉丽,李雪丽,孔冉,等.中医药治疗肠道菌群失调症的方剂用药规律分析[J].中国实验方剂学杂志,2018,24(12):210-215.
[50]杜旦锋,郭丽,祝利民.大肠癌微生态与脾虚证的相关研究现状及思考[J].浙江中医杂志,2018,53(2):154-155.
[51]张玉佩,杨钦河,邓远军,等.中焦湿热证与胃肠道微生态关系刍议[J].中医杂志,2016,57(24):2094-2096.
[52]吴云,陈瑞,田维毅.苦寒中药对肠道菌群结构影响的研究进展[J].中国微生态学杂志,2015,27(2):235-239.
[53]崔国宁,刘喜平,曾庆涛.参苓白术散治疗溃疡性结肠炎研究进展[J].中华中医药学刊,2018,36(2):391-395.
[54]劳武健,邓亮,吴青志.参苓白术颗粒联合匹维溴铵治疗腹泻型肠易激综合征的临床观察[J].云南中医中药杂志,2018,39(9):50-52.
[55]李军婷,张美琳,李卓.参苓白术散联合双歧三联活菌胶囊治疗抗生素相关腹泻疗效分析[J].云南中医学院学报,2018,41(2):41-43.
[56]李铁,刘平,及东林.参苓白术散联合盐酸洛哌丁胺胶囊治疗腹腔镜胆囊切除术后腹泻疗效及对肠道菌群及胃肠激素的影响[J].现代中西医结合杂志,2017,26(19):2097-2101.
[57]冯新格,严育忠,曾艺鹏,等.葛根芩连汤对2型糖尿病湿热证肠道菌群的影响[J].世界中西医结合杂志,2016,11(8):1110-1112.
[58]谭朝晖,刘荣火,邹立华,等.白头翁汤对溃疡性结肠炎黏膜愈合的影响及部分机制研究[J].中国中医药信息杂志,2016,23(7):30-34.
[59]刘靖.痛泻要方治疗腹泻型肠易激综合征的疗效观察及其对肠道菌群的影响[D].北京:中国中医科学院,2017.
[60]陈维,孟宪萌,关乐,等.大柴胡汤对冠心病不稳定型心绞痛血清Ghrelin和Obestatin的表达及肠道菌群构成的影响[J].中国实验方剂学杂志,2018,24(12):169-174.
[61]钟雄利,谭小燕,任伟旺,等.大承气汤联合西医治疗重症急性胰腺炎的疗效及其对肠黏膜屏蔽功能的影响[J].中国中西医结合消化杂志,2015,23(4):242-244.
[62]张双喜,张相安,安永康.济川煎对老年慢性功能性便秘患者胃肠功能、血清肠神经递质及肠道菌群的影响[J].中国实验方剂学杂志,2018,24(22):169-174.
[63]余静芳.理中汤联合恩替卡韦对乙型肝炎肝硬化代偿期肠道微生态的影响[D].南宁:广西中医药大学,2017.
[64]李吉武,唐爱华,赵伟,等.温阳益气活血方对肥胖2型糖尿病患者肠道菌群变化及脂质代谢的影响[J].中医杂志,2015,56(5):409-413.
[65]李超然,刘德柱,杨燕,等.针灸对慢性疲劳综合征及肠道菌群的作用研究[J].针灸临床杂志,2018,34(7):89-92.
[66]覃佩兰,成泽东.基于脑肠轴学说探讨针灸对肠道菌群调节的思考[J].时珍国医国药,2015,26(11):2712-2714.
[67]苏冬梅,刘新平,黄静娟,等.神阙穴隔姜灸对腹泻型肠易激综合征患者肠道双歧杆菌影响[J].辽宁中医药大学学报,2018,20(5):135-138.
[68]高小明,常虹,丁超华.柴芍承气汤灌肠联合生长抑素对重症胰腺炎患者腹内高压及肠道黏膜屏障的影响[J].中医药导报,2017,23(6):96-98.
[69]王荣荣,曹志尉,孟静.大黄牡丹汤保留灌肠联合血液净化治疗重症急性胰腺炎的临床疗效及对患者肠黏膜屏障功能和炎症因子的影响[J].中国中医急症,2018,27(9):1618-1620.
[70]孔月晴,赵振宇.拔罐合耳穴贴压疗法对单纯性肥胖患者肠道菌群的影响[J].中国临床研究,2016,29(2):257-259.